These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38130094)

  • 1. Integrating long-acting reversible contraceptives into primary care internal medicine practices: A clinical innovation to reduce wait time.
    Quinn SM; Goldfarb Terry R; Boock S; Shea JA
    Womens Health (Lond); 2023; 19():17455057231219569. PubMed ID: 38130094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-visit insertion of long-acting reversible contraception in a single health system.
    Stuart GS; Yates L; Crump J; Allison BA; Navarro AL; Tadikonda A; Neal-Perry G; Arora KS
    Contraception; 2023 Jul; 123():110009. PubMed ID: 36931546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Barriers to Provision of Long-Acting Reversible Contraception in Wisconsin.
    Olson EM; Kramer RD; Gibson C; Wautlet CK; Schmuhl NB; Ehrenthal DB
    WMJ; 2018 Oct; 117(4):149-155. PubMed ID: 30407764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Evaluation of Contraceptive Methods After Implementation of a Novel LARC Program in a Residency Primary Care Clinic.
    Gopinath VV; Monteiro JFG; Carr A; Sobota M; Geary M; McGarry K
    R I Med J (2013); 2022 Apr; 105(3):57-59. PubMed ID: 35349624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revolving Loan Fund: A Novel Approach to Increasing Access to Long-Acting Reversible Contraception Methods in Community Health Centers.
    Evans ML; Breeze JL; Paulus JK; Meadows A
    J Public Health Manag Pract; 2017; 23(6):684-689. PubMed ID: 28628582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
    Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
    Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
    Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Accessibility to Long-Acting Reversible Contraception in a Public Health Setting.
    DeBoer TH; Hensley JG
    Nurs Womens Health; 2018 Aug; 22(4):302-309. PubMed ID: 30077236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IUD services among primary care practices in New York City.
    Jacobson L; Garbers S; Helmy H; Roobol H; Kohn JE; Kavanaugh ML
    Contraception; 2016 Mar; 93(3):257-62. PubMed ID: 26569447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
    Thompson CM; Broecker J; Dade M
    J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
    Davis SA; Braykov NP; Lathrop E; Haddad LB
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers.
    Murphy MK; Stoffel C; Nolan M; Haider S
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):436-442. PubMed ID: 26851537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving LARC Access for Urban Adolescents and Young Adults in the Pediatric Primary Care Setting.
    Onyewuchi UF; Tomaszewski K; Upadhya KK; Gupta PS; Whaley N; Burke AE; Trent ME
    Clin Pediatr (Phila); 2019 Jan; 58(1):24-33. PubMed ID: 30318927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Practice Transformation and Long-Acting Reversible Contraception (LARC) Use in Adolescents.
    Schiavoni KH; Lawrence J; Xue J; Kotelchuck M; Boudreau AA
    Acad Pediatr; 2022 Mar; 22(2):296-304. PubMed ID: 34758402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
    Bryson AE; Cabral HJ; Coles MS
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
    Smith AJB; Harney KF; Singh T; Hurwitz AG
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.